AAMAX
Price
$13.23
Change
-$0.31 (-2.29%)
Updated
Jun 5 closing price
Net Assets
76.61M
CRAZX
Price
$11.36
Change
-$0.24 (-2.07%)
Updated
Jun 5 closing price
Net Assets
2.56B
Interact to see
Advertisement

AAMAX vs CRAZX

Header iconAAMAX vs CRAZX Comparison
Open Charts AAMAX vs CRAZXBanner chart's image
AAMAX vs CRAZX Comparison Chart in %
View a ticker or compare two or three
VS
AAMAX vs. CRAZX commentary
Jun 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAMAX is a Buy and CRAZX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CRAZX has more cash in the bank: 2.56B vs. AAMAX (76.6M). CRAZX pays higher dividends than AAMAX: CRAZX (2.63) vs AAMAX (0.00). AAMAX was incepted earlier than CRAZX: AAMAX (10 years) vs CRAZX (14 years). AAMAX (1.82) is less costly to investors than CRAZX (0.81). CRAZX is a more actively managed with annual turnover of: 186.00 vs. AAMAX (78.00). CRAZX has a lower initial minimum investment than AAMAX: CRAZX (2000) vs AAMAX (2500). CRAZX annual gain was more profitable for investors over the last year : 18.43 vs. AAMAX (13.95). AAMAX return over 5 years is better than : 12.02 vs. CRAZX (10.27).
AAMAXCRAZXAAMAX / CRAZX
Total Expense Ratio1.820.81225%
Annual Report Gross Expense Ratio1.820.81225%
Fund Existence10 years14 years-
Gain YTD6.7807.27193%
Front Load6%N/A-
Min. Initial Investment25002000125%
Min. Initial Investment IRAN/AN/A-
Net Assets76.6M2.56B3%
Annual Yield % from dividends0.002.63-
Returns for 1 year13.9518.4376%
Returns for 3 years34.0440.1285%
Returns for 5 years12.0210.27117%
Returns for 10 years35.6343.4882%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRFH2.22N/A
N/A
Barfresh Food Group
LAD288.84-1.76
-0.61%
Lithia Motors
TRS39.17-0.38
-0.96%
TriMas Corp
GEV933.61-29.72
-3.09%
GE Vernova
DMAC5.64-0.20
-3.42%
DiaMedica Therapeutics